| Marion Joyce Colburn, MD, MPH | |
|
1 Med Center Dr., Morgantown, WV 26506 | |
| (304) 293-2436 | |
| Not Available |
| Full Name | Marion Joyce Colburn |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 20 Years |
| Location | 1 Med Center Dr., Morgantown, West Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295902062 | NPI | - | NPPES |
| 26720 | Other | WV | STATE MEDICAL LICENSE |
| 7995A | Other | WY | STATE MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | D0067038 (Maryland) | Secondary |
| 208M00000X | Hospitalist | D67038 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Calverthealth Medical Center | Prince frederick, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Medicine Associates Pa Pc | 8022914522 | 382 |
News Archive
MIT has received $90 million from Ludwig Cancer Research, on behalf of its founder Daniel K. Ludwig, a gift that aims to transform basic research on metastasis, the process by which cancer cells spread from a primary tumor to distant sites in the body.
Lightbeam Health Solutions announced today a contract agreement with Veritas to deploy the Lightbeam population health analytics platform.
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its recently launched pain reliever, Cobroxin, was selected as the "Best New Product" at the Efficient Collaborative Retail Marketing (ECRM) Conference. Cobroxin was chosen as the award recipient by conference attendees, including several of the leading national retailers.
A new study has found that the occurrence of advanced forms of a diabetic eye disease remains low among children living with diabetes, regardless of how long they have had the disease or their ability to keep blood sugar levels controlled. Researchers are therefore recommending that most children with type 1 diabetes delay annual diabetic retinopathy screenings until age 15, or 5 years after their diabetes diagnosis, whichever occurs later.
› Verified 3 days ago
| Entity Name | Emergency Medicine Associates Pa Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134117393 PECOS PAC ID: 8022914522 Enrollment ID: O20040126000955 |
News Archive
MIT has received $90 million from Ludwig Cancer Research, on behalf of its founder Daniel K. Ludwig, a gift that aims to transform basic research on metastasis, the process by which cancer cells spread from a primary tumor to distant sites in the body.
Lightbeam Health Solutions announced today a contract agreement with Veritas to deploy the Lightbeam population health analytics platform.
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its recently launched pain reliever, Cobroxin, was selected as the "Best New Product" at the Efficient Collaborative Retail Marketing (ECRM) Conference. Cobroxin was chosen as the award recipient by conference attendees, including several of the leading national retailers.
A new study has found that the occurrence of advanced forms of a diabetic eye disease remains low among children living with diabetes, regardless of how long they have had the disease or their ability to keep blood sugar levels controlled. Researchers are therefore recommending that most children with type 1 diabetes delay annual diabetic retinopathy screenings until age 15, or 5 years after their diabetes diagnosis, whichever occurs later.
› Verified 3 days ago
| Entity Name | Chester River Hospital Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679536809 PECOS PAC ID: 0749220671 Enrollment ID: O20050510000504 |
News Archive
MIT has received $90 million from Ludwig Cancer Research, on behalf of its founder Daniel K. Ludwig, a gift that aims to transform basic research on metastasis, the process by which cancer cells spread from a primary tumor to distant sites in the body.
Lightbeam Health Solutions announced today a contract agreement with Veritas to deploy the Lightbeam population health analytics platform.
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its recently launched pain reliever, Cobroxin, was selected as the "Best New Product" at the Efficient Collaborative Retail Marketing (ECRM) Conference. Cobroxin was chosen as the award recipient by conference attendees, including several of the leading national retailers.
A new study has found that the occurrence of advanced forms of a diabetic eye disease remains low among children living with diabetes, regardless of how long they have had the disease or their ability to keep blood sugar levels controlled. Researchers are therefore recommending that most children with type 1 diabetes delay annual diabetic retinopathy screenings until age 15, or 5 years after their diabetes diagnosis, whichever occurs later.
› Verified 3 days ago
| Entity Name | Upper Chesapeake Emergency Medicine Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285854026 PECOS PAC ID: 2860587342 Enrollment ID: O20070927001103 |
News Archive
MIT has received $90 million from Ludwig Cancer Research, on behalf of its founder Daniel K. Ludwig, a gift that aims to transform basic research on metastasis, the process by which cancer cells spread from a primary tumor to distant sites in the body.
Lightbeam Health Solutions announced today a contract agreement with Veritas to deploy the Lightbeam population health analytics platform.
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its recently launched pain reliever, Cobroxin, was selected as the "Best New Product" at the Efficient Collaborative Retail Marketing (ECRM) Conference. Cobroxin was chosen as the award recipient by conference attendees, including several of the leading national retailers.
A new study has found that the occurrence of advanced forms of a diabetic eye disease remains low among children living with diabetes, regardless of how long they have had the disease or their ability to keep blood sugar levels controlled. Researchers are therefore recommending that most children with type 1 diabetes delay annual diabetic retinopathy screenings until age 15, or 5 years after their diabetes diagnosis, whichever occurs later.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marion Joyce Colburn, MD, MPH 2574 Misty Ridge Cv, Annapolis, MD 21401-6828 Ph: (804) 307-9235 | Marion Joyce Colburn, MD, MPH 1 Med Center Dr., Morgantown, WV 26506 Ph: (304) 293-2436 |
News Archive
MIT has received $90 million from Ludwig Cancer Research, on behalf of its founder Daniel K. Ludwig, a gift that aims to transform basic research on metastasis, the process by which cancer cells spread from a primary tumor to distant sites in the body.
Lightbeam Health Solutions announced today a contract agreement with Veritas to deploy the Lightbeam population health analytics platform.
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its recently launched pain reliever, Cobroxin, was selected as the "Best New Product" at the Efficient Collaborative Retail Marketing (ECRM) Conference. Cobroxin was chosen as the award recipient by conference attendees, including several of the leading national retailers.
A new study has found that the occurrence of advanced forms of a diabetic eye disease remains low among children living with diabetes, regardless of how long they have had the disease or their ability to keep blood sugar levels controlled. Researchers are therefore recommending that most children with type 1 diabetes delay annual diabetic retinopathy screenings until age 15, or 5 years after their diabetes diagnosis, whichever occurs later.
› Verified 3 days ago
Dr. James Robert Welty, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Drive, Morgantown, WV 26506 Phone: 304-598-4000 | |
Dr. Ramana Reddy Guduru, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Drive, Morgantown, WV 26507 Phone: 304-293-1964 | |
Tien Huu Nguyen, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 304-598-4850 | |
Avery James Gookin, PA-C Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1300 Fort Pierpont Dr Ste 101, Morgantown, WV 26508 Phone: 304-241-7150 Fax: 304-599-8917 | |
Maryum Hussain, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 304-598-4000 | |
Dr. Faraz Syed Alam, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Drive, West Virginia University -department Of Family Medicine, Morgantown, WV 26506 Phone: 304-598-6907 | |
Katelynn Stickley, PA-C Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 J D Anderson Dr, Morgantown, WV 26505 Phone: 304-598-1200 Fax: 304-598-1699 |